GlassScriptPhysician profile
Peter Razeghi
NPI 1316116981
$5,631.07
in general payments reported to CMS, 2019-2025
37 companies · $843 in 2025
The $843 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $393 · 2020: $431 · 2021: $1,051 · 2022: $1,031 · 2023: $968 · 2024: $914 · 2025: $843.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,725.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $882.67 | 2019-2025 | Watchman Flx, Watchman Access System, Resonate El Icd Vr |
| Amgen INC. | $682.23 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $399.45 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $386.03 | 2021-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $385.28 | 2019-2025 | Eliquis, Camzyos |
| Medtronic, INC. | $366.47 | 2021-2025 | Azure Xt Dr Mri Surescan, Micra, Mycarelink |
| Novartis Pharmaceuticals Corporation | $332.76 | 2020-2024 | |
| Abbott Laboratories | $283.11 | 2020-2025 | Aveir, Cardiomems, Confirm Rx |
| Amarin Pharma, INC. | $270.13 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $254.54 | 2021-2024 | Verquvo, Lagevrio |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $179.23 | 2019-2025 | Lifevest |
| Esperion Therapeutics, INC. | $151.33 | 2020-2024 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $132.17 | 2020-2024 | Farxiga |
| Medtronic Vascular, INC. | $99.09 | 2019-2020 | |
| Kiniksa Pharmaceuticals, LTD. | $91.21 | 2022-2023 | Arcalyst |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Razeghi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.